Single-Dose Intranasal Vaccination Elicits Systemic and Mucosal Immunity against SARS-CoV-2

0
22
Scientists reported the development of an intranasal subunit vaccine that uses lyophilized spike protein and liposomal STING agonist as an adjuvant.
[iScience]
An, X., Martinez-Paniagua, M., Rezvan, A., Sefat, S. R., Fathi, M., Singh, S., Biswas, S., Pourpak, M., Yee, C., Liu, X., & Varadarajan, N. (2021). Single-dose intranasal vaccination elicits systemic and mucosal immunity against SARS-CoV-2. IScience, 0(0). https://doi.org/10.1016/j.isci.2021.103037 Cite
AbstractFull ArticleGraphical Abstract